Nisa Investment Advisors
AZN icon

Nisa Investment Advisors’s AstraZeneca AZN Stock Holding History

Nisa Investment Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$137K Buy
721
+52
+8% +$9.78K ﹤0.01% 1391
2026
Q1 		$132K Buy
669
+25
+4% +$4.82K ﹤0.01% 1336
2025
Q4 		$118K Buy
644
+69
+12% +$12.1K ﹤0.01% 1382
2025
Q3 		$88.2K Hold
575
– – ﹤0.01% 1472
2025
Q2 		$80.4K Sell
575
-125
-18% -$17.5K ﹤0.01% 1463
2025
Q1 		$103K Buy
700
+375
+115% +$54.3K ﹤0.01% 1397
2024
Q4 		$42.6K Sell
325
-575
-64% -$80.5K ﹤0.01% 1728
2024
Q3 		$140K Hold
900
– – ﹤0.01% 1362
2024
Q2 		$140K Buy
900
+700
+350% +$105K ﹤0.01% 1394
2024
Q1 		$27.1K Sell
200
-100
-33% -$13.2K ﹤0.01% 1798
2023
Q4 		$40.4K Hold
300
– – ﹤0.01% 1689
2023
Q3 		$40.6K Hold
300
– – ﹤0.01% 1790
2023
Q2 		$42.9K Hold
300
– – ﹤0.01% 1799
2023
Q1 		$42K Sell
300
-19,000
-98% -$2.56M ﹤0.01% 1768
2022
Q4 		$2.62M Buy
19,300
+19,000
+6,333% +$2.38M 0.02% 655
2022
Q3 		$33K Sell
300
-8,431
-97% -$1.07M ﹤0.01% 1892
2022
Q2 		$1.15M Hold
8,731
– – 0.01% 782
2022
Q1 		$1.16M Buy
+8,731
New +$1.05M 0.01% 819
2021
Q4 		– Sell
-5,937
Closed -$713K – 2220
2021
Q3 		$713K Buy
+5,937
New +$691K ﹤0.01% 1019
2020
Q3 		– Sell
-2,400
Closed -$254K – 2249
2020
Q2 		$254K Hold
2,400
– – ﹤0.01% 1225
2020
Q1 		$214K Sell
2,400
-550
-19% -$51.8K ﹤0.01% 1176
2019
Q4 		$294K Sell
2,950
-1,150
-28% -$108K ﹤0.01% 1233
2019
Q3 		$365K Hold
4,100
– – ﹤0.01% 1180
2019
Q2 		$338K Hold
4,100
– – ﹤0.01% 1188
2019
Q1 		$332K Hold
4,100
– – ﹤0.01% 1175
2018
Q4 		$311K Sell
4,100
-200
-5% -$15.6K ﹤0.01% 1131
2018
Q3 		$340K Buy
+4,300
New +$325K ﹤0.01% 1203

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nisa Investment Advisors's AZN Position: Q2 2026 in Review

Nisa Investment Advisors increased its AstraZeneca (AZN) stake by 7.8% in Q2 2026, buying an estimated $9.78K and bringing the position to 721 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Nisa Investment Advisors first reported a position in AZN in Q3 2018 and has held it in 27 quarters since. The position peaked at $2.62M in Q4 2022. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nisa Investment Advisors held 721 shares of AstraZeneca worth $137K as of Q2 2026.
  • Nisa Investment Advisors bought 52 AstraZeneca shares in Q2 2026, an estimated $9.78K.
  • AstraZeneca made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1391 holding.
  • Nisa Investment Advisors first reported a position in AstraZeneca in Q3 2018 and has held it in 27 quarters since.
  • Nisa Investment Advisors's AstraZeneca position peaked at $2.62M in Q4 2022.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.